For example, any drug ending in -olol will be a member of the class of beta-adrenoceptor antagonists (e.g., atenolol, propranolol) and any drug ending in -mab will be a monoclonal antibody (e.g., rituximab). The system for International Nonproprietary Names for pharmaceutical compounds is...
"over, against, opposite; instead, in the place of; as good as; at the price of; for the sake of; compared with; in opposition to; in return; counter-," from PIE *anti "against," also "in front of, before" (from root *ant- "front, forehead," with derivatives meaning "in ...
Augmenting previous findings, we show that amidation of the lipid II stem peptide predominantly accounts for the increased binding of oritavancin to the modified intermediates ending in D-Ala-D-Lac. Corroborating our conclusions, we further provide biochemical evidence for the phenomenon of the ...
4), were introduced as anticancer and antitumor drugs in 1980s. Later, several other anticancer agents of microbial origins have appeared which include esperamicin, dinemicina, kedarcidina, namenamycin, C-1027 chromophore, maturepeptina, N1999A2 and shishijimicin A, and most recently ...